Published Date:2024-09-27 Original Link:https://www.onenessbio.com/en/news_detail322_1.htm No 1 Date of announcement 2024/09/27 Time of announcement 17:33:59 Subject Oneness Biotech Co., Ltd. receives a United States patent titled “TREATING IGE-MEDIATED ALLERGIC DISEASES” on FB825. To which item it meets paragraph 53 Date of events 2024/09/27 Statement Date of occurrence of the event: 2024/09/27 Company name: ONENESS BIOTECH CO.,...Read More
Published Date:2024-09-20 Original Link:https://www.onenessbio.com/en/news_detail321_1.htm No 1 Date of announcement 2024/09/20 Time of announcement 18:46:22 Subject Oneness has received medical device registration approval on Bonvadis Topical Cream for Egypt To which item it meets paragraph 10 Date of events 2024/09/20 Statement Date of occurrence of the event: 2024/09/20 New drug name or code: Bonvadis Indication: Bonvadis...Read More
Published Date:2024-09-18 Original Link:https://www.onenessbio.com/en/news_detail320_1.htm No 1 Date of announcement 2024/09/18 Time of announcement 17:43:20 Subject Oneness announces the information about the investor’s conference of 2024 Q3. To which item it meets paragraph 12 Date of events 2024/09/25 Statement Date of institutional investor conference: 2024/09/25 Time of institutional investor conference: 15:00 (GMT+8) Location of institutional investor...Read More
Published Date:2024-09-15 Original Link:https://www.onenessbio.com/en/news_detail319_1.htm No 1 Date of announcement 2024/09/15 Time of announcement 20:15:58 Subject National Health Security Administration of China has not included Fespixon Cream in this year NRDL adjustment negotiation after the expert review. To which item it meets paragraph 53 Date of events 2024/09/14 Statement Date of occurrence of the event: 2024/09/14...Read More
Published Date:2024-09-08 Original Link:https://www.onenessbio.com/en/news_detail317_1.htm No 1 Date of announcement 2024/09/08 Time of announcement 17:16:12 Subject SNS812 Phase 2 study demonstrated statistical significance in treating COVID-19 based on its safety, precision and broad-spectrum efficacy. To which item it meets paragraph 10 Date of events 2024/09/06 Statement Date of occurrence of the event: 2024/09/06 New drug name...Read More
Published Date:2024-09-08 Original Link:https://www.onenessbio.com/en/news_detail318_1.htm No 2 Date of announcement 2024/09/08 Time of announcement 18:18:59 Subject Oneness & Microbio (Shanghai) host an international press conference to present the pan-COVID new drug, SNS812 Phase 2 clinical trial results and future prospects To which item it meets paragraph 53 Date of events 2024/09/08 Statement Date of occurrence of...Read More
Published Date:2024-09-05 Original Link:https://www.onenessbio.com/en/news_detail316_1.htm No 2 Date of announcement 2024/09/05 Time of announcement 17:58:20 Subject The post hoc analysis of the global novel drug, Fespixon (ON101), on hard-to-heal diabetic foot ulcers has been published in Advances in Wound Care To which item it meets paragraph 53 Date of events 2024/09/05 Statement Date of occurrence of...Read More
Published Date:2024-09-05 Original Link:https://www.onenessbio.com/en/news_detail315_1.htm No 1 Date of announcement 2024/09/05 Time of announcement 15:30:21 Subject The Company’s security trading have reached threshold of mandatory disclosure of financial information per TPEx requirements To which item it meets paragraph 53 Date of events 2024/09/05 Statement Date of occurrence of the event:2024/09/05 Cause of occurrence:Proceeded according to the...Read More
Published Date:2024-08-27 Original Link:https://www.onenessbio.com/en/news_detail314_2.htm No 1 Date of announcement 2024/08/27 Time of announcement 17:13:16 Subject Oneness Biotech Co., Ltd. receives a Japanese patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101). To which item it meets paragraph 53 Date of events 2024/08/27 Statement Date of occurrence of the event: 2024/08/27...Read More
Published Date:2024-08-15 Original Link:https://www.onenessbio.com/en/news_detail313_2.htm No 1 Date of announcement 2024/08/15 Time of announcement 15:50:03 Subject Oneness Biotech Co., Ltd. receives a Philippine patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101). To which item it meets paragraph 53 Date of events 2024/08/15 Statement Date of occurrence of the event: 2024/08/15...Read More
